Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.
Lugthart, S Figueroa, M Bindels, E Skrabanek, L Valk, P J M Li, Y Meyer, Stefan Erpelinck-Verschueren, C Greally, J Löwenberg, B
Lugthart, S
Figueroa, M
Bindels, E
Skrabanek, L
Valk, P J M
Li, Y
Meyer, Stefan
Erpelinck-Verschueren, C
Greally, J
Löwenberg, B
Citations
Altmetric:
Abstract
DNA methylation patterns are frequently dysregulated in cancer, although little is known of the mechanisms through which specific gene sets become aberrantly methylated. The ecotropic viral integration site 1 (EVI1) locus encodes a DNA binding zinc-finger transcription factor that is aberrantly expressed in a subset of acute myeloid leukemia (AML) patients with poor outcome. We find that the promoter DNA methylation signature of EVI1 AML blast cells differs from those of normal CD34(+) bone marrow cells and other AMLs. This signature contained 294 differentially methylated genes, of which 238 (81%) were coordinately hypermethylated. An unbiased motif analysis revealed an overrepresentation of EVI1 binding sites among these aberrantly hypermethylated loci. EVI1 was capable of binding to these promoters in 2 different EVI1-expressing cell lines, whereas no binding was observed in an EVI1-negative cell line. Furthermore, EVI1 was observed to interact with DNA methyl transferases 3A and 3B. Among the EVI1 AML cases, 2 subgroups were recognized, of which 1 contained AMLs with many more methylated genes, which was associated with significantly higher levels of EVI1 than in the cases of the other subgroup. Our data point to a role for EVI1 in directing aberrant promoter DNA methylation patterning in EVI1 AMLs.
Description
Date
2011-01-06
Publisher
Collections
Keywords
Type
Article
Citation
Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1. 2011, 117 (1):234-41 Blood